Concepedia

Xiaoqing Xu

XX

29

Publications

917

Citations

19

H-Index

2008

Active since

Affiliations

Shandong First Medical University(Current)

Shandong Tumor Hospital

Harbin Medical University

University of California, Los Angeles

Kaiser Permanente

Xiaoqing Xu is an author at Shandong First Medical University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2008–2024

29

Publications

29

Cardiovascular Disease After Aromatase Inhibitor Use

Reina Haque, Jiaxiao Shi, Joanne E. Schottinger et al. · JAMA Oncology · 2016 · 101 citations · Full text

Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study

Reina Haque, Xiaoqing Xu, Andrea E. Cassidy‐Bushrow et al. · British Journal of Cancer · 2017 · 71 citations · Full text

Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors

Xiaoqing Xu, Rowan T. Chlebowski, Jiaxiao Shi et al. · Breast Cancer Research and Treatment · 2019 · 64 citations

, , +13

Long-term outcome of penile appearance and sexual function after hypospadias repairs: situation and relation

Chenwei Jiao, Rongde Wu, Xiaoqing Xu et al. · International Urology and Nephrology · 2010 · 58 citations

, , +10

Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway

Xiaoqing Xu, Xinyue Zhang, Yang Zhang et al. · Biomedicine & Pharmacotherapy · 2021 · 57 citations · Full text

Rows per page

1–5 of 29